I hope you have enjoyed the summer recess and that the prospect of winter, shortening days and continued bed shortages doesn't fill you with too much gloom.
There have been three publicised cases which will have implications for the practice of critical care in the United Kingdom. The first is the Burke judgement (where the GMC guidelines on withdrawal of treatment were deemed unlawful and Mr Burke won the right to continue to receive artificial hydration and nutrition when he becomes increasingly incapacitated by his disease). The second is the Glass case which went to the European Court of Appeal. This arose as a result of a disagreement between the mother and the paediatricians about the appropriateness of further resuscitation should the son develop another life threatening respiratory complication. The final case is the baby at Portsmouth who was born so prematurely that her cardiorespiratory system is unable to support her development and she will shortly succumb. All these cases have a similar thread; the question of treatment in the face of a progressively debilitating chronic disease which will ultimately be fatal. Some colleagues might retort that patients with these types of diseases are not admitted to their intensive care units. As medicine develops, it is probably just a matter of time until such referrals and requests for help are made. Furthermore as patients and their relatives become better informed (but alas not necessarily more knowledgeable) they are likely to request or demand invasive support. It is even more likely that attempts will be made to apply the rulings made in specific areas (such as the Burke judgement) to other more general intensive care. Indeed the Society has already received a pamphlet from a firm of solicitors entitled 'When should doctors go to courtvoluntarily?'. This pamphlet whilst attempting to be informative was based on the solicitors' interpretation on the Burke judgement and understandably was probably more encompassing than the original judgement. The pamphlet clearly advocates more referral to the courts in decisions concerning withdrawal of treatment. Intensivists are likely to come under pressure from families and from the legal profession.
Clearly it is very important that the critical care fraternity responds to and meets this challenge for, not only the patients with terrible slowly progressive degenerative diseases but all our patients who might benefit from our services. In the course of critical illness, there is rarely time to obtain a court order as the patient descends further into multiple organ failure. However, having to delay care pathways while court orders are obtained would have far reaching implications for bed usage. We might have in our care several patients awaiting the courts' deliberations. Of the 78,000 adult patients receiving intensive care, approximately 25% will die whilst in the ICU; for 50% of these patients (i.e. 10,000), treatment is withdrawn on the basis of futility. What will be the impact on those patients who (as yet) do not have the support of a court order and are denied access to our services (especially those following elective surgery).
We need to protect ourselves (and indeed our patients) against this well intentioned but misdirected (or perhaps more accurately mis-interpreted) guidance of our practice. Ultimately we will probably have to wait until a specific case concerning ICU comes to court to obtain a firm decision. However as the decision is made by others not directly connected or concerned with the care of the critically ill, we have a duty to inform. In this way at least the decision can be fair and most importantly realistic. One just has to look at the section concerning research in unconscious adults in the Mental Incapacity Bill to see what can be considered reasonable when medical advice is either not sought or ignored.
While not advocating a return to paternalism, there is a place for leadership whereby we provide the facts and a knowledge of the constraints of medical practice to those who make the judgements. How are we going to provide this leadership locally? Dealing specifically with the Burke judgement, there are important factors to be made clear. Mr Justice Munby limited his judgement to artificial hydration and nutrition and not to the withdrawal of other organ support measures applied daily in ICU. The Judge went on to say that when the patient is dying, then artificial hydration and nutrition can be withdrawn because at that stage these interventions are bereft of benefit. So when discussing the implications of this judgement it is important to remind other colleagues (possibly outside critical care) and relatives of the restrictive nature of the named treatment (i.e. in this case artificial hydration and nutrition) and that treatment can be withdrawn when the patient is dying.
Furthermore perhaps we should begin to be more precise in our definition of the dying patient (and that is a term that we should use more frequently in discussions with the relatives of those most seriously ill) and the definition of ICU treatments. The invasive organ support, the hallmark of intensive care, is in fact just that; organ support. It could be argued that IPPV is not a treatment for pneumonia in the same way as the antibiotics. Unfortunately it is the lack of IPPV that tends to damage the patient rather than the short-term lack of antibiotics. Trying to formulate the definition of dying and the difference between general organ support and specific treatment may clarify our own thinking and also allow us to lead others. Some may say that it is all words and the distinctions between treatments and organ support are at best small, probably blurred and in truth don't exist. However, the precise meaning of words is important and it is vital that in this important area of our practice, they have the meaning that we want them to have.
Patients and relatives information
Imparting information to patients and relatives is always time consuming and frequently a difficult task. To help improve communication with families (one of the factors which families rate as most important in terms of overall satisfaction with the care provided), the Society has, in conjunction with Red Door Communications, developed a patient information booklet (now downloadable from the website) and a patient forum. I would encourage you to look at this new area of the website and see if any areas may be of help to you, other staff members and of course your patients.
Elections
At the end of each year the Society calls for nominations for possible election to Council. If you have an interest in shaping the future of the Society then please consider standing for election to Council. The nomination papers will be distributed at the start of the New Year. The vigour of the Society is reflected in its Council elections and I would encourage those members eligible to vote to exercise their prerogative. For any member who is considering standing for election further details of the work involved can be obtained from the Honorary Secretary. The Royal College of Anaesthetists will also be holding their council elections in the winter and a number of eminent intensivists, such as Dr Andrew Cohen, are standing. Our specialty needs strong voices on the various College councils.
Finally as ever I would encourage you to make use of the Society's web page for communication with your colleagues around the country and I hope to see as many of you as possible at the Society's State of the Art meeting on December 13th and 14th in London.
Saxon Ridley

Big Academic, Randomised Controlled Trial completed: PAC-Man Study update.
Completion of the PAC-Man Study, the biggest trial of pulmonary artery catheters in patient management in intensive care, is a fantastic achievement for the UK critical care community. We're delighted to report that data from 1,014 patients were included in the study analysis, giving the study 82.5% power to detect a 10% change in mortality in patients managed with a PAC. The results of the study have been shared with our participating units and will be presented to the wider critical care community in October 2004 at the European Society of Intensive Care Medicine Annual Congress in Berlin, and at the UK ICS State of the Art Meeting in December 2004. The paper is almost ready for submission to the Lancet and will hopefully be published in the very near future.
